7 results
Alectinib versus Crizotinib in Untreated ALK-Positive Non–Small-Cell Lung Cancer #EBM #Honc #Alectinib #Crizotinib #ALK #ALKPositive #NSCLC
Crizotinib in Untreated ALK-Positive ... Lung Cancer #EBM #Honc ... Alectinib #Crizotinib #ALK ... #ALKPositive #NSCLC ... VisualAbstract #NEJM
Progression-free Survival  #EBM #Honc #Osimertinib #NSCLC #Survival #NEJM
Survival #EBM #Honc ... #Osimertinib #NSCLC ... #Survival #NEJM
Diagnostic Algorithm for Non–Small-Cell Lung Cancer (NSCLC). The upper portion of the algorithm shows the morphologic
classification of NSCLC ... mutations and ALK ... #Diagnosis #Honc ... #Algorithm #NSCLC ... #PDL1 #NEJM
Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer - Progression-free Survival in the Intention-to-Treat Population.
#EBM #Honc #PACIFIC ... #Durvalumab #NSCLC ... #NEJM
The Mechanism of Small Interfering RNA (siRNA) Therapy. Synthetic double-stranded RNA containing an ALAS1-specific sequence is
level of delta ALA ... production of ALA ... #Pathophys #Honc ... siRNA #Therapy #NEJM
Perirenal Extramedullary Hematopoiesis - Magnetic resonance imaging of the abdomen, performed without the administration of contrast
hemosiderin deposition, all ... Radiology #Pathology #Honc ... ExtramedullaryHematopoiesis #Microscopy #NEJM
Approach Cardiac Conduction Device Infections (from NEJM link below)
Baddour LM et al. N Engl J Med
Infections (from NEJM ... Baddour LM et al ... DeviceInfections #Pocket #Algorithm